Serum levels of soluble vascular cell adhesion molecule-1, tumor necrosis factor-α, and interleukin-6 in in vitro fertilization cycles

Fertility and Sterility

Volumn 91, Issue 5 SUPPL., 2009, Pages 2012-2019

  Souter, Irene ^a   Huang, Andy ^a   Martinez Maza, Otoniel ^a   Crabb Breen, Elizabeth ^a   Decherney, Alan H ^a   Chaudhuri, Gautam ^a   Nathan, Lauren ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

E2; in vitro fertilization; interleukin 6; Soluble vascular adhesion molecule 1; tumor necrosis factor

Indexed keywords

ESTRADIOL; FOLLITROPIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR PHASE; FOLLITROPIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; INFLAMMATION; LUTEAL PHASE; MATERNAL AGE; OOCYTE RETRIEVAL; PRIORITY JOURNAL; SERUM; STATISTICAL ANALYSIS;

ADULT; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; FOLLICULAR PHASE; HUMANS; INFERTILITY, FEMALE; INTERLEUKIN-6; LUTEAL PHASE; OOCYTE RETRIEVAL; PATIENT SELECTION; PREGNANCY; PREGNANCY OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 65049087238     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.04.039     Document Type: Article

References (76)

1. Libby P. Vascular biology of atherosclerosis: overview and state of the art. [Review]. Am J Cardiol 91 (2003) 3A-6A
2. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
3. Morisaki N., Saito I., Tamura K., Tashiro J., Masuda M., Kanzaki T., et al. New indices of ischemic heart disease and aging; studies on the serum levels of intercellular adhesion molecule-1 (ICAM-1) and soluble vascular adhesion molecule-1 (VCAM-1) in patients with hypercholesterolemia and ischemic heart disease. Atherosclerosis 131 (1997) 43-48
4. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon III R.O., Criqui M., et al. Centers for Disease Control and Prevention. American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
5. Van der Wal A., Das P., and Tigges A. Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am J Pathol 141 (1992) 1427-1433
6. Tzoulaki I., Murray G., Lee Am Rumley A., Lowe G., and Fowkes G. C-Reactive protein, interleukin-6 and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population. Edinburg Artery Study. Circulation 112 (2005) 976-983
7. Butcher E.C. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 67 (1991) 1033-1036
8. Carlos T.M., and Harlan J.M. Leukocyte-endothelial adhesion molecules. Blood 84 (1994) 2068-2101
9. Gearing J.H., and Newman W. Circulating adhesion molecules in disease. Immunol Today 14 (1993) 506-512
10. Gearing J.H., Hemingway I., Pigott R., Hughes J., Rees A.J., and Cashman S.J. Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1 and VCAM-1: pathologic significance. Ann N Y Acad Sci 40 (1993) 324-331
11. Ley K. Molecular mechanisms of leukocyte recruitment in inflammatory process. Cardiovasc Res 32 (1996) 733-742
12. Lewinsohn D.M., Bargatze R.F., and Butcher E.C. Leukocyte-endothelial cell recognition: evidence of a common molecular mechanism shared by neutrophils, lymphocytes and other leukocytes. J Immunol 138 (1987) 4313-4321
13. Marik A.B., and Lo A.S. Vascular endothelial molecules and tissue inflammation. Pharmacol Rev 48 (1996) 213-229
14. Cybulsky M.I., and Gimbrone M.A. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 252 (1991) 788-791
15. Li H., Cybulsky M.I., Gimbrone Jr. M.A., and Libby P. Inducible expression of vascular cell adhesion molecule-1 by vascular smooth cells in vitro and within rabbit atheroma. Am J Pathol 143 (1993) 1551-1559
16. O' Brien K.D., Allen M.D., McDonald T.O., Chait A., Harlan J.M., Fishbein D., et al. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest 92 (1993) 945-951
17. Lobb R.R., Chi-Rosso G., Leone D.R., Rosa M.D., Bixler S., Newman B.M., et al. Expression and functional characterization of a soluble form of endothelial-leukocyte adhesion molecule 1. J Immunol 147 (1991) 124-129
18. Daniel Y., Geva E., Amit A., Baram A., Englander T., Kupferminc M.J., et al. Levels of soluble vascular cell adhesion molecule-1 and soluble intercellular adhesion molecule-1 are increased in women with ovarian hyperstimulation syndrome. Fertil Steril 71 (1999) 896-901
19. Higgins J.R., Papayianni A., Brady H.R., Darling M.R., and Walshe J.J. Circulating vascular cell adhesion molecule-1 in pre-eclampsia, gestational hypertension, and normal pregnancy: evidence of selective dysregulation of vascular cell adhesion molecule-1 homeostasis in pre-eclampsia. Am J Obstet Gynecol 179 (1998) 464-469
20. Vinatier D., Orazi G., Cosson M., and Dufour P. Theories of endometriosis. Eur J Obstet Gynecol Reprod Biol 96 (2001) 21-34
21. Pigot R., Dillon L.P., Hemingway I.H., and Garing A.J. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Bioph Res Comm 187 (1992) 584-589
22. Brady H.R. Leukocyte adhesion molecules and kidney diseases. Kidney Int 45 (1994) 1285-1300
23. 4 integrins. J Immun 170 (2003) 5704-5711
24. Bochner B.S., Klunk D.A., Sterbinsky S.A., Coffman R.L., and Schleimer R.P. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J Immunol 154 (1995) 799-803
25. Masinovsky B., Urdal D., and Gallatin W.M. IL-4 acts synergistically with IL-1 beta to promote lymphocyte adhesion to microvascular endothelium by induction of vascular cell adhesion molecule-1. J Immun 145 (1990) 2886-2895
26. Osborn L., Hession C., Tizard R., Vassallo C., Luhowskyj S., Chi-Rosso G., et al. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 59 (1989) 1203-1211
27. Sakumoto R., and Okuda K. Possible actions of tumor necrosis factor-α in ovarian function. J Reprod Dev 50 (2004) 39-46
28. Von der T., Kuiper J., Van Berkel T.J.C., and Biessen E.A.L. Interleukins in atherosclerosis: molecular pathways and therapeutic potential. Pharmacol Rev 55 (2003) 133-166
29. Harris T.B., Ferrucci L., Tracy R.P., Corti M.C., Wacholder S., Ettinger W.H., et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 106 (1999) 506-512
30. Ridker P.M., Rifai N., Pfeffer M., Sacks F., Lepage S., Braunwald E., et al. Elevation of tumor necrosis factor-α and increased risk of recurrent coronary events after myocardial infarction. Circulation 101 (2000) 2149-2153
31. Ridker P.M., Rifai N., Stampfer M.J., and Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101 (2000) 1767-1772
32. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
33. Cushman M., Legault C., Barrett-Connor E., Stefanick M.L., Kessler C., Judd H.L., et al. Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) study. Circulation 100 (1999) 717-722
34. Jilma B., Hildebrandt J., Kapiotis S., Wagner O.F., Kitzweger E., Mullner C., et al. Effects of estradiol on circulating P-selectin. J Clin Endo Metab 81 (1996) 2350-2355
35. Koh K.K., Bui M.N., Mincemoyer R., and Cannon R.O. Effects of hormone therapy on inflammatory cell adhesion molecules in postmenopausal healthy women. Am J Cardiol 80 (1997) 1505-1507
36. Oger E., Alhenc-Gelas M., Plu-Bureau G., Guize L., and Scarabin P.Y. Plasma 17β-estradiol is inversely correlated with circulating vascular cell adhesion molecule. Thromb Haemost 84 (2000) 1125
37. Scarabin P.Y., Alhenc-Gelas M., Oger E., and Plu-Bureau G. Hormone replacement therapy and circulating ICAM-1 in postmenopausal women. A randomized controlled trial. Thromb Haemost 81 (1999) 673-675
38. Seljeflot I., Arnesen H., Hofstad A.E., and Os I. Reduced expression of endothelial cell markers after long-term transdermal hormone replacement therapy in women with coronary artery disease. Thromb Haemost 83 (2000) 944-948
39. Van Baal W.M., Emeis J.J., Kenemans P., Kessel H., Peters-Muller E.R., Schalkwijk C.G., et al. Short-term hormone replacement therapy: reduced plasma levels of soluble adhesion molecules. Eur J Clin Invest 29 (1999) 913-921
40. Zanger D., Yang B.K., Ardans J., Waclawiw M.A., Csako G., Wahl L.M., et al. Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management. J Am Coll Cardiol 36 (2000) 1797-1802
41. Caulin-Glaser T., Watson C.A., Pardi R., and Bender J.R. Effects of 17beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression. J Clin Invest 98 (1996) 36-42
42. Cid M.C., Kleinman H.K., Grant D.S., Schnaper H.W., Fauci A.S., and Hoffman G.S. Estradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1, and vascular cell adhesion molecule type 1. J Clin Invest 93 (1994) 17-25
43. Dickens G.R., Matheny C.J., Morris P.E., Clifton G.D., and Ensom M.H. A pilot study of estrogen's effects on bronchial myocyte adhesion molecule expression. Pharmacotherapy 19 (1999) 1426-1431
44. Simoncini T., De Caterina R., and Genazzani A.R. Selective estrogen receptor modulators: different actions on vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cells. J Clin Endo Metab 84 (1999) 815-818
45. Nathan L., Pervin S., Singh R., Rosenfeld M., and Chaudhuri G. Estradiol inhibits leukocyte adhesion and transendothelial migration in rabbits in vivo: possible mechanisms for gender differences in atherosclerosis. Circulation Research 85 (1999) 377-85.29
46. Mukherjee T.K., Nathan L., Dinh H., Reddy St, and Chaudhuri G. 17-epiestriol, an estrogen metabolite, is more potent than estradiol in inhibiting vascular cell adhesion molecule 1 (VCAM-1) mRNA expression. J Biol Chem 278 (2003) 11746-11752
47. Bonello N., and Norman R.J. Soluble adhesion molecules in serum throughout the menstrual cycle. Hum Reprod 17 (2002) 2272-2278
48. Chiu K.M., Arnaud A.D., Ju J., Mayes D., Bacchetti P., Weitz S., et al. Correlation of estradiol, parathyroid hormone, interleukin-6, and soluble interleukin-6 receptor during the normal menstrual cycle. Bone 26 (2000) 79-85
49. Jilma B., Dirnmerger E., Löshcher I., Rumplmayr A., HildenBrandt J., Eichler H.G., et al. Menstrual cycle associated changes in blood levels of interleukin-6, alpha 1 acid glycoprotein, and C-reactive protein. J Lab Clin Med 130 (1997) 69-75
50. Amato G., Conte M., Gherardo M., Lalli E., Vitolo G., Tucker A., et al. Serum and follicular fluid cytokines in polycystic ovary syndrome during stimulated cycles. Obstet Gynecol 101 (2003) 1177-1182
51. Souter I., Janzen C., Martinez-Maza O., Crabb-Breen E., Stanczyk F., Chaudhuri G., et al. Serum levels of soluble vascular cell adhesion molecule-1 are decreased in women receiving oral contraceptives compared with normally menstruating women: Implications in atherosclerosis. Fertil Steril 83 (2005) 1480-1488
52. Sumino H., Ichikawa S., Kasama S., Kumakura H., Takayama Y., Sakamaki T., et al. Effect of transdermal hormone replacement therapy on carotid artery wall thickness and levels of vascular inflammatory markers in postmenopausal women. Hypertens Res Clin Exper 28 (2005) 579-584
53. Eilertsen A.L., Hoibraaten E., Os I., Andersen T.O., Sanvik L., and Sandset P.M. The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis. Maturitas 52 (2005) 111-118
54. Hemelaar M., Van Der Mooren M.J., Van Baal W.M., Schalkwijk C.G., Kenemans P., and Stehouwer C.D.A. Effects of transdermal and oral postmenopausal hormone therapy on vascular function: a randomized, placebo-controlled study in healthy postmenopausal women. Menopause 12 (2005) 526-535
55. Ray A., Prefontaine K.E., and Ray P. Down modulation of interleukin-6 gene expression by 17-beta estradiol by the estrogen receptor. J Biol Chem 269 (1994) 12940-12946
56. Mendelsohn M.E. Genomic and nongenomic effects of estrogen in vasculature. Am J Cardiol 90 (2002) 3F-6F
57. Mukherjee T.K., Mishra A.K., Mukhopadhyay S., and Hoidal J.R. High concentration of antioxidants N-acetylcysteine and mitoquinone-Q induces intercellular adhesion molecule 1 and oxidative stress by increasing intracellular glutathione. J Immunol 178 (2007) 1835-1844
58. Adashi E.Y., Resnick C.E., Packman J.N., Hurwitz A., and Payne D.W. Cytokine mediated regulation of ovarian function: tumor necrosis factor α inhibits gonadotropin-supported progesterone accumulation by differentiating and luteinized murine granulosa cells. Am J Obstet Gynecol 162 (1990) 889-899
59. Zolti M., Meirom R., Shemesh M., Wollach D., Mashiach S., Shore L., et al. Granulosa cells as source and target organ for tumor necrosis α. FEBS Lett 261 (1990) 253-255
60. Motro B., Itin A., Sachs L., and Keshet E. Pattern of interleukin-6 gene expression in vitro suggests a role for this cytokine in angiogenesis. Proc Natl Acad Sci USA 87 (1990) 3092-3096
61. Sakumoto R., and Okuda K. Possible actions of tumor necrosis factor-a in ovarian function. J Reprod Dev 50 (2004) 39-46
62. Mandrup-Poulsen T., Nerup J., Reimers J.I., Pociot F., Andersen H.U., Karlsen A., et al. Cytokine and the endocrine system. The immunoendocrine network. Eur J Endocrinol 133 (1995) 660-671
63. Loret de Mola J.R., Baumgardner G.P., Goldfarb J.M., and Friedlander M.A. Ovarian hyperstimulation syndrome: preovulatory serum concentration of IL-6, interleukin-1 receptor antagonist and tumor necrosis factor alpha cannot predict its occurrence. Hum Reprod 11 (1996) 1377-1380
64. Buyalos R.P., Watson J.M., and Martinez-Maza O. Detection of interleukin-6 in human follicular fluid. Fertil Steril 57 (1992) 1230-1234
65. Brännström M., Friden B., Jasper M., and Norman R. Variations in peripheral blood levels of immunoreactive tumor necrosis factor alpha (TNF-α) throughout the menstrual cycle and secretion of TNF-α from the human corpus luteum. Eur J Obstet Gynecol Repro Biol 83 (1999) 213-217
66. Babayof R., Margalioth E., Huleihel M., Amash A., Zyllber-Haran E., Gal M., et al. Serum inhibin A, VEGF and TNF-α levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial. Hum Reprod 21 (2006) 1260-1265
67. Manau D., Arroyo V., Jimenez W., Fabregues F., Vanrell J., and Balasch J. Chronology of hemodynamic changes in asymptomatic in vitro fertilization patients and relationship with ovarian steroids and cytokines. Fertil Steril 77 (2002) 1178-1183
68. Machelon V., Emilie D., Lefevre A., Nome F., Duran-Gasselin I., and Testart J. Interleukin-6 biosynthesis in human preovulatory follicles: some of its potential roles at ovulation. J Clin Endocrinol Metab 79 (1994) 633-642
69. Jasper M., and Norman R.J. Immunoreactive interleukin-1 beta and tumour necrosis factor-alpha in thecal, stromal and cell granulosa cell cultures from normal and polycystic ovaries. Hum Reprod 10 (1995) 1352-1354
70. Zolti M., Bider D., Seidman D.S., Mashiach S., and Ben-Rafael Z. Cytokine levels in follicular fluid of polycystic ovaries in patients treated with dexamethasone. Fertil Steril 57 (1992) 501-504
71. Koka S., Petro T.M., and Reinhardt R.A. Estrogen inhibits interleukin-1 beta-induced interleukin-6 production by human osteoblast-like cells. J Interferon Cytokine Res 18 (1998) 479-482
72. Kurebayashi S., Miyashita Y., Hirose T., Kasayama S., Akira S., and Kishimoto T. Characterization of mechanisms of interleukin-6 gene repression by estrogen receptor. J Ster Biochem Molec Biol 60 (1997) 11-17
73. Pottratz S.T., Bellido T., Mocharla H., Crabb D., and Manolagas S.C. 17β estradiol inhibits expression of human promoter-reporter constructs by a receptor-dependent mechanism. J Clinc Investig 93 (1994) 944-950
74. Kassem M., Kossla S., Spelsber T.C., and Riggs B.L. Cytokine production in the bone marrow microenvironment: failure to demonstrate estrogen regulation in early postmenopausal women. J Clinical Endo Metab 81 (1996) 513-518
75. Richard D., Russel G., and Gowen M. Oestradiol inhibits the release of tumor necrosis factor but not interleukin 6 from adult human osteoblasts in vitro. Osteopor Int 2 (1992) 94-102
76. Rifas L., Kenney J.S., Marcelli M., Pacifici R., Cheng S.-L., Sawson L.L., et al. Production of interleukin-6 in human osteoblasts and human bone marrow stromal cells: evidence that induction by interleukin-1 and tumor necrosis factor-α is not regulated by ovarian steroids. Endocrinology 136 (1995) 4056-4067